NCT00002345已完成4 期
Phase IV Study on the Safety and Efficacy of Megace Oral Suspension in HIV-Positive Females
Bristol-Myers Squibb8 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 8
研究概览
简要总结
To further evaluate the safety of megestrol acetate (Megace) oral suspension in the treatment of anorexia and cachexia in HIV-positive women. To compare the effectiveness of 2 doses of Megace by measurement of weight gain, appetite grade, and other parameters at 12 and 24 weeks.
详细描述
Patients are randomized to receive 1 of 2 doses of Megace oral suspension daily for 24 weeks; at 12 weeks, those receiving the lower dose who have not gained 5 pounds over baseline or had appetite improvement to good or excellent are escalated to the higher dose. Patients are evaluated at 4-week intervals. Dose may be adjusted to maintain a desired weight.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (8)
Loading locations...
相似试验
终止
3 期
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer PatientsAnorexiaCachexiaWeight LossNCT00637728Par Pharmaceutical, Inc.5
撤回
2 期
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of AppetiteAnorexiaNCT01501396Washington University School of Medicine
尚未招募
Unknown
A phase II study of appetite stimulant megestrol acetate in patients receiving chemotherapy after gastric cancer surgeryNeoplasmsKCT0008479Pusan National University Yangsan Hospital54
撤回
4 期
Pharmacokinetics and Safety of Transdermal Megestrol AcetateCachexiaNCT00163072Milton S. Hershey Medical Center
已完成
3 期
Effect of Megestrol Acetate plus Celecoxib versus Megestrol Acetate alone in CachexiaCachexia.CachexiaIRCT201407222027N4Mazandaran University of Medical Scienses80